Skip to main content
Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.448
+0.034 (8.12%)
At close: Mar 9, 2026, 4:00 PM EDT
0.423
-0.024 (-5.45%)
After-hours: Mar 9, 2026, 7:01 PM EDT

Outlook Therapeutics Revenue

Outlook Therapeutics had revenue of $-1.21M in the quarter ending December 31, 2025. This brings the company's revenue in the last twelve months to $205.70K. In the fiscal year ending September 30, 2025, Outlook Therapeutics had annual revenue of $1.41M.

Revenue (ttm)
$205.70K
Revenue Growth
n/a
P/S Ratio
180.75
Revenue / Employee
$12,100
Employees
17
Market Cap
37.18M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 20251.41M--
Sep 30, 2024---
Sep 30, 2023---
Sep 30, 2022---
Sep 30, 2021---
Sep 30, 2020 Pro Pro Pro
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Atara Biotherapeutics 151.93M
Celularity 40.58M
NovaBay Pharmaceuticals 10.30M
Pluri 1.34M
Lisata Therapeutics 1.07M
ABVC BioPharma 797.92K
Actinium Pharmaceuticals 90.00K
INmune Bio 50.00K
Revenue Rankings

OTLK News

More News